Home > Akebia Therapeutics Salary

Akebia Therapeutics Salary

  • 85
  • 27
  • 28
Akebia Therapeutics average salary is $29,526, median salary is $29,526 with a salary range from $28,683 to $30,368.
Akebia Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Akebia Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
28,683
Average
29,526
Median
29,526
High
30,368
Total 2 Akebia Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
International Business Development Specialist 28,683-28,683 Collegedale, TN, 37315 2015 Akebia Therapeutics International Business Development Specialist Salaries (2)
Akebia Therapeutics Collegedale, TN Salaries
International Business Development Specialist 30,368-30,368 Collegedale, TN, 37315 2014 Akebia Therapeutics International Business Development Specialist Salaries (2)
Akebia Therapeutics Collegedale, TN Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Akebia Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Akebia Therapeutics Jobs
See more Akebia Therapeutics Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
516

All Patents

109

Grant Patents

337

Patents Pending

117

Patents Families

More Recent
Akebia Therapeutics... Information
  • Akebia Therapeutics Inc
  • Industry: BioTech/Drugs
  • City: Cincinnati, OH
  • Founded in Cincinnati in 2007, Akebia in-licensed its initial drug development programs and assets from Procter & Gamble. These programs have multiple drug candidates with animal proof-of-concept data, and Akebia is currently focused on developing treatments for anemia and vascular disease.